Innate Pharma S.A.
IPHA
Cena:
$ 1.83
-0.14 (-7.11%)
Valuace
70
Růst
30
Zdraví
75
Zprávy
Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF DECEMBER 31, 2025
07-01-2026
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: PURSUANT TO THE ARTICLE L. 233...
Více zde
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF DECEMBER 18, 2025
22-12-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: PURSUANT TO THE ARTICLE L. 233...
Více zde
INNATE PHARMA RELEASES ITS 2026 FINANCIAL CALENDAR
11-12-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PAR...
Více zde
NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF NOVEMBER 27, 2025
28-11-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)--NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF NOVEMB...
Více zde
INNATE PHARMA REPORTS THIRD QUARTER 2025 BUSINESS UPDATE AND FINANCIAL RESULTS
13-11-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PAR...
Více zde
INNATE PHARMA ANNOUNCES FDA CLEARANCE TO PROCEED WITH TELLOMAK 3, A CONFIRMATORY PHASE 3 TRIAL OF LACUTAMAB IN CTCL
10-11-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PA...
Více zde
INNATE PHARMA ANNOUNCES CONFERENCE CALL AND WEBCAST FOR THIRD QUARTER 2025 RESULTS AND BUSINESS UPDATES
05-11-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PAR...
Více zde
INNATE PHARMA TO HOST ANALYST AND INVESTOR EVENT ON LACUTAMAB ON OCTOBER 28, 2025
14-10-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PAR...
Více zde
INNATE PHARMA REPORTS FIRST HALF 2025 BUSINESS UPDATE AND FINANCIAL RESULTS
17-09-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--INNATE PHARMA REPORTS FIRST HALF 2025 BUSINESS ...
Více zde
INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN THE 25TH EDITION OF THE EUROPEAN MIDCAP EVENT
15-09-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ANKET--INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN THE 25TH E...
Více zde
INNATE PHARMA ANNOUNCES CONFERENCE CALL AND WEBCAST FOR FIRST HALF 2025 FINANCIAL RESULTS AND BUSINESS UPDATE
10-09-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ANKET--INNATE PHARMA ANNOUNCES CONFERENCE CALL AND WEBCAST FOR...
Více zde
INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN THE BTIG VIRTUAL BIOTECHNOLOGY CONFERENCE
29-07-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IRCONFERENCE--INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN BTI...
Více zde
INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN H.C. WAINWRIGHT AND WOLFE RESEARCH HEALTHCARE CONFERENCES
17-06-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #INVESTORRELATIONS--INNATE PHARMA ANNOUNCES ITS PARTICIPATION I...
Více zde
INNATE PHARMA HIGHLIGHTS PRECLINICAL ANTITUMOR ACTIVITY OF IPH6501 IN DIFFUSE LARGE B-CELL LYMPHOMA AND FOLLICULAR LYMPHOMA AT THE 2025 EUROPEAN HEMATOLOGY ASSOCIATION (EHA) CONGRESS
13-06-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ANKET--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH;...
Více zde
INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN JEFFERIES AND GOLDMAN SACHS HEALTHCARE CONFERENCES
27-05-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IRCONFERENCES--INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN UP...
Více zde
OUTCOME OF INNATE PHARMA'S 2025 ANNUAL GENERAL MEETING
23-05-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #AG--OUTCOME OF INNATE PHARMA'S 2025 ANNUAL GENERAL MEETING....
Více zde
INNATE PHARMA HIGHLIGHTS ABSTRACTS SELECTED FOR ASCO 2025 ANNUAL MEETING
19-05-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ANKET--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH;...
Více zde
INNATE PHARMA HIGHLIGHTS ANKET® ABSTRACTS SELECTED FOR THE EHA 2025 CONGRESS
15-05-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ANKET--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH;...
Více zde
INNATE PHARMA REPORTS FIRST QUARTER 2025 BUSINESS UPDATE AND FINANCIAL RESULTS
13-05-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ADC--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH; N...
Více zde
INNATE PHARMA ANNOUNCES CONFERENCE CALL AND WEBCAST FOR Q1 2025 BUSINESS UPDATE
06-05-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #INNATEPHARMA--INNATE PHARMA ANNOUNCES CONFERENCE CALL AND WEBC...
Více zde
INNATE PHARMA FILES ITS 2024 UNIVERSAL REGISTRATION DOCUMENT (DOCUMENT D'ENREGISTREMENT UNIVERSEL) AND 2024 ANNUAL REPORT ON FORM 20-F
30-04-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ANKET--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH;...
Více zde
INNATE PHARMA HIGHLIGHTS PRECLINICAL ANTI-TUMOR EFFICACY DATA OF ITS ANTIBODY DRUG CONJUGATE IPH4502 AT THE AACR 2025 ANNUAL MEETING
29-04-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #AACR--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH; ...
Více zde
INNATE PHARMA ANNOUNCES €15M INVESTMENT BY SANOFI
24-04-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ANKET--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH;...
Více zde
INNATE PHARMA REGAINS ITS RIGHTS ON CD123 TARGETING ANKET® AND ANNOUNCES SANOFI'S INTENTION TO MAKE A STRATEGIC INVESTMENT IN THE COMPANY
23-04-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ANKET--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH;...
Více zde
INNATE PHARMA PROPOSES TO ITS SHAREHOLDERS TO TRANSFORM ITS CORPORATE GOVERNANCE STRUCTURE INTO A BOARD OF DIRECTORS AND TO CHANGE ITS COMPOSITION
16-04-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)--INNATE PHARMA PROPOSES TO ITS SHAREHOLDERS TO TRANSFORM ITS CORP...
Více zde
INNATE PHARMA REPORTS FULL YEAR 2024 FINANCIAL RESULTS AND BUSINESS UPDATE
27-03-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ADC--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH; N...
Více zde
INNATE PHARMA HIGHLIGHTS ANTIBODY DRUG CONJUGATE IPH4502 ABSTRACT SELECTED FOR THE AACR 2025 ANNUAL MEETING
26-03-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #ADC--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH; N...
Více zde
INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN THE LIFE SCIENCES VAN LANSCHOT KEMPEN CONFERENCE
25-03-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)--INNATE PHARMA ANNOUNCES ITS PARTICIPATION IN THE LIFE SCIENCES V...
Více zde
INNATE PHARMA ANNOUNCES CONFERENCE CALL AND WEBCAST FOR FULL YEAR 2024 FINANCIAL RESULTS
20-03-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)--INNATE PHARMA ANNOUNCES CONFERENCE CALL AND WEBCAST FOR FULL YEA...
Více zde
INNATE PHARMA TO PARTICIPATE IN THE 2025 LEERINK PARTNERS GLOBAL HEALTHCARE CONFERENCE
27-02-2025
MARSEILLE, FRANCE--(BUSINESS WIRE)--INNATE PHARMA TO PARTICIPATE IN THE 2025 LEERINK PARTNERS GLOBAL...
Více zde
Dokumenty nejsou k dispozici
